Tag Archives: ADAP

Top 5 Clean Energy Stocks To Own Right Now

What happened 

Shares of natural gas distributor Clean Energy Fuels Corp. (NASDAQ:CLNE) were down 10.2% at the close of trading Monday on no real news. Shares were down as much as 11.8% in early morning trading, and were down by high single digits for most of the day. 

So what

Oddly enough, crude oil is trading slightly higher today with WTI crude up 0.3% and Brent crude up 1.5% on the day, which is usually a bullish sign for Clean Energy Fuels. Natural gas is also down 1%, which should lower input costs, another factor that usually pushes the stock higher. 

Image source: Getty Images.

Sometimes stocks trade on momentum or factors that have nothing to do with fundamentals, and that appears to be what’s happening today. Shares were also down double digits last Thursday on an analyst downgrade, so this could be momentum from that move as well. 

Top 5 Clean Energy Stocks To Own Right Now: Adaptimmune Therapeutics plc(ADAP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Adaptimmune Therapeutics (NASDAQ:ADAP) was downgraded by stock analysts at TheStreet from a “c-” rating to a “d+” rating in a research report issued to clients and investors on Monday.

  • [By Logan Wallace]

    Adaptimmune Therapeutics (NASDAQ:ADAP) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.

  • [By Ethan Ryder]

    Adaptimmune Therapeutics (NASDAQ:ADAP) announced its quarterly earnings data on Wednesday. The biotechnology company reported ($0.04) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.24) by $0.20, Bloomberg Earnings reports. Adaptimmune Therapeutics had a negative return on equity of 32.26% and a negative net margin of 185.39%. During the same quarter in the prior year, the business earned ($3.00) EPS.

  • [By ]

    Adaptimmune Therapeutics (ADAP) : “If you’ve speculated on this one, you’ve won. Let’s move on.”

    Icahn Enterprises (IEP) : “I don’t really know what they own so I can’t recommend it.”

  • [By Logan Wallace]

    Here are some of the news stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get Adaptimmune Therapeutics alerts:

    Analysts Anticipate Adaptimmune Therapeutics PLC – (ADAP) to Post -$0.28 Earnings Per Share (americanbankingnews.com) Peritoneal Cancer Market Pipeline Review H1- Target Drug Profile, Top Industry Intelligence, Major Key Players and … (thefreenewsman.com) Escherichia coli Infections Market Research Report Pipeline Review H1 Assessment by Mechanism of Action, Drug … (theperfectinvestor.com) Adaptimmune Therapeutics plc (ADAP): Do You Have This Stock in Portfolio?: (bitcoinpriceupdate.review)

    Several equities analysts have weighed in on the company. Leerink Swann reissued an “outperform” rating on shares of Adaptimmune Therapeutics in a report on Thursday, March 15th. BidaskClub downgraded Adaptimmune Therapeutics from a “hold” rating to a “sell” rating in a research report on Wednesday. ValuEngine upgraded Adaptimmune Therapeutics from a “buy” rating to a “strong-buy” rating in a research report on Monday. SunTrust Banks increased their target price on Adaptimmune Therapeutics to $18.00 and gave the stock a “buy” rating in a research report on Thursday, May 10th. Finally, Cowen restated a “buy” rating on shares of Adaptimmune Therapeutics in a research report on Wednesday, May 9th. Two equities research analysts have rated the stock with a sell rating, four have given a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $16.94.

  • [By ]

    Cramer was bearish on Chesapeake Energy (CHK) , Adaptimmune Therapeutics (ADAP) , Icahn Enterprises (IEP) , Bristol-Myers Squibb (BMY) , Quad/Graphics (QUAD) , Spectra Energy Partners (SEP) and L Brands (LB) .

Top 5 Clean Energy Stocks To Own Right Now: TerraForm Power, Inc.(TERP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Entergy (NYSE: ETR) and TerraForm Power (NASDAQ:TERP) are both utilities companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership and analyst recommendations.

  • [By Matthew DiLallo]

    Brookfield Renewable Partners is one of the largest publicly traded renewable power generators in the world. The company focuses on producing hydropower, which currently comprises 76% of its portfolio, though it also has exposure to the wind and solar markets, due in part to its investment in TerraForm Power (NASDAQ:TERP). Brookfield sells about 87% of the power it produces under long-term contracts, which lock in prices, thus allowing it to generate stable cash flow. The company currently pays out about 90% of that cash to investors to support its high-yielding distribution, but aims to get that number down to 70% over the long term.

  • [By Matthew DiLallo]

    TerraForm Power (NASDAQ:TERP) has come a long way since Brookfield Asset Management (NYSE:BAM) took control of the renewable-power-generating company last fall. At the time, the pair unveiled an ambitious turnaround plan to improve TerraForm’s legacy operations and reposition it for future growth. That strategy is working out even better than the companies initially anticipated, which was evident in its second-quarter report.

  • [By Tyler Crowe, Sean Williams, and Brian Stoffel]

    So we asked three Motley Fool contributors to highlight a stock they think is a great dividend investment today. Here’s why they picked Big Lots (NYSE:BIG), Enviva Partners (NYSE:EVA), and TerraForm Power (NASDAQ:TERP). 

  • [By Matthew DiLallo]

    In addition to the embedded growth within its existing portfolio, Brookfield Renewable has the potential to continue making acquisitions to power an even faster growth rate. Brookfield has a long history of making needle-moving deals, including closing several in the last year. In October, it invested $203 million to acquire a 16% stake in wind and solar company TerraForm Power (NASDAQ:TERP). It followed that up by spending $230 million for a 31% interest in TerraForm Global in December and then boosting its stake in TerraForm Power up to 31% this summer by investing another $217 million into that company.

Top 5 Clean Energy Stocks To Own Right Now: Hawaiian Telcom Holdco, Inc.(HCOM)

Advisors’ Opinion:

  • [By Max Byerly]

    News coverage about Hawaiian Telcom HoldCo (NASDAQ:HCOM) has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Hawaiian Telcom HoldCo earned a news impact score of 0.06 on Accern’s scale. Accern also assigned media coverage about the utilities provider an impact score of 46.776618457707 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top 5 Clean Energy Stocks To Own Right Now: NETGEAR, Inc.(NTGR)

Advisors’ Opinion:

  • [By Max Byerly]

    Netgear (NASDAQ:NTGR) has received a consensus recommendation of “Buy” from the seven brokerages that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, five have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $74.50.

  • [By Max Byerly]

    ValuEngine upgraded shares of NetGear (NASDAQ:NTGR) from a hold rating to a buy rating in a research report sent to investors on Tuesday morning.

    Other analysts also recently issued research reports about the stock. BidaskClub downgraded shares of NetGear from a strong-buy rating to a buy rating in a research report on Tuesday, June 26th. TheStreet downgraded shares of NetGear from a b- rating to a c+ rating in a research report on Monday, August 13th. Raymond James set a $80.00 target price on shares of NetGear and gave the stock a buy rating in a research report on Wednesday, September 5th. Cowen assumed coverage on shares of NetGear in a research report on Monday. They set a hold rating and a $63.00 target price for the company. Finally, Zacks Investment Research raised shares of NetGear from a strong sell rating to a hold rating in a research report on Wednesday, June 27th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company’s stock. The company presently has an average rating of Hold and an average price target of $70.40.

  • [By Ethan Ryder]

    Silvercrest Asset Management Group LLC lowered its stake in shares of NetGear, Inc. (NASDAQ:NTGR) by 99.0% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,386 shares of the communications equipment provider’s stock after selling 840,960 shares during the quarter. Silvercrest Asset Management Group LLC’s holdings in NetGear were worth $480,000 at the end of the most recent reporting period.

Top 5 Clean Energy Stocks To Own Right Now: Aurora Cannabis Inc. (ACBFF)

Advisors’ Opinion:

  • [By Keith Speights]

    Other Canadian marijuana growers could also jump into the fray. Last month, BNN Bloomberg reported that Molson Coors (NYSE:TAP) was in discussions with several Canadian companies, including Aurora Cannabis (NASDAQOTH:ACBFF) and Aphria (NASDAQOTH:APHQF), about collaborating on cannabis-infused beverages. The report also indicated that Molson Coors was potentially interested in investing in a Canadian marijuana grower, as Constellation Brands did.

  • [By Shanthi Rexaline]

    Aurora Cannabis Inc (OTC: ACBFF) recently announced a deal to buy MedReleaf Corp (OTC: MEDFF) in an all-cash transaction valued at C$3.2 billion.

  • [By Sean Williams]

    The bigger catalyst was the announcement that Aurora Cannabis (NASDAQOTH:ACBFF) would buy MedReleaf in an all-share deal valued at around $2.5 billion. Although the deal hasn’t closed, it represents a healthy premium from where MedReleaf had been trading when the deal was announced. It would also give Aurora Cannabis a genuine shot to lead all growers in annual production. Aurora Cannabis estimates that the combined entity would be capable of 570,000 kilograms of cannabis production a year when at full capacity. 

  • [By Keith Speights]

    Marijuana grower

    Canopy Growth Corporation (NYSE:CGC) $5.8 billion
      Aurora Cannabis (NASDAQOTH: ACBFF) $2.9 billion
      Tilray (NASDAQ: TLRY) $2.3 billion
      Aphria (NASDAQOTH: APHQF) $1.9 billion
      MedMen Enterprises (NASDAQOTH: MMNFF) $1.3 billion
      Cronos Group (NASDAQ: CRON) $1 billion
      The Green Organic Dutchman (NASDAQOTH: TGODF) $1 billion
      The Hydropothecary (NASDAQOTH: HYYDF) $728 million
      CannTrust Holdings (NASDAQOTH: CNTTF) $513 million
      Organigram Holdings (NASDAQOTH: OGRMF) $509 million
      Marimed (NASDAQOTH: MRMD) $472 million
      TerrAscend (NASDAQOTH: TRSSF) $398 million
      Auxly Cannabis (NASDAQOTH: CBWTF) $368 million
      iAnthus Capital Holdings (NASDAQOTH: ITHUF) $367 million
      Medical Marijuana (NASDAQOTH: MJNA) $330 million
      CV Sciences (NASDAQOTH: CVSI) $299 million
      Emerald Health Therapeutics (NASDAQOTH: EMHTF) $287 million
      Supreme Cannabis (NASDAQOTH: SPRWF) $277 million
      Smart Cannabis (NASDAQOTH: SCNA) $276 million
      MPX Bioceutical (NASDAQOTH: MPXEF) $234 million
      AusCann Group Holdings (NASDAQOTH: ACNNF) $223 million
      Liberty Health Sciences (NASDAQOTH: LHSIF) $213 million

    Biotech

Top 10 High Tech Stocks To Buy For 2019

Equities research analysts expect Clorox Co (NYSE:CLX) to report sales of $1.53 billion for the current quarter, according to Zacks. Five analysts have provided estimates for Clorox’s earnings, with the highest sales estimate coming in at $1.55 billion and the lowest estimate coming in at $1.52 billion. Clorox posted sales of $1.50 billion in the same quarter last year, which would indicate a positive year over year growth rate of 2%. The firm is scheduled to report its next earnings report on Wednesday, November 7th.

According to Zacks, analysts expect that Clorox will report full year sales of $6.34 billion for the current fiscal year, with estimates ranging from $6.30 billion to $6.37 billion. For the next financial year, analysts forecast that the business will report sales of $6.52 billion per share, with estimates ranging from $6.48 billion to $6.53 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Clorox.

Top 10 High Tech Stocks To Buy For 2019: Acadia Realty Trust(AKR)

Advisors’ Opinion:

  • [By Shane Hupp]

    Corecivic (NYSE:CXW) and Acadia Realty Trust (NYSE:AKR) are both mid-cap finance companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Acadia Realty Trust (AKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribing]

    Acadia Realty Trust (NYSE:AKR) Q4 2018 Earnings Conference CallFeb. 14, 2019 12:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 High Tech Stocks To Buy For 2019: Zumiez Inc.(ZUMZ)

Advisors’ Opinion:

  • [By Shane Hupp]

    Zumiez (NASDAQ:ZUMZ) CEO Richard Miles Brooks sold 3,957 shares of Zumiez stock in a transaction dated Wednesday, June 6th. The shares were sold at an average price of $27.00, for a total transaction of $106,839.00. Following the completion of the sale, the chief executive officer now owns 3,709,067 shares in the company, valued at approximately $100,144,809. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Zumiez (ZUMZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Zumiez (ZUMZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Zumiez (NASDAQ:ZUMZ) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday.

  • [By Max Byerly]

    Divisar Capital Management LLC reduced its position in shares of Zumiez Inc. (NASDAQ:ZUMZ) by 81.6% in the 2nd quarter, HoldingsChannel reports. The firm owned 26,994 shares of the apparel and footwear maker’s stock after selling 120,085 shares during the period. Zumiez comprises approximately 0.2% of Divisar Capital Management LLC’s holdings, making the stock its 26th largest position. Divisar Capital Management LLC’s holdings in Zumiez were worth $676,000 as of its most recent filing with the Securities & Exchange Commission.

Top 10 High Tech Stocks To Buy For 2019: Ambarella, Inc.(AMBA)

Advisors’ Opinion:

  • [By Ashraf Eassa]

    Video processor maker Ambarella (NASDAQ:AMBA) was once a red-hot stock, thanks in large part to its position as a key chip supplier in GoPro (NASDAQ:GPRO) action cameras. Unfortunately for Ambarella, GoPro’s success was relatively short-lived, and on top of that, GoPro ultimately designed Ambarella out of future products. During the company’s most recent earnings call, Ambarella CFO Casey Eichler said that “GoPro continued to be immaterial in the current quarter.” 

  • [By Max Byerly]

    Ambarella (NASDAQ:AMBA) last released its quarterly earnings data on Thursday, November 29th. The semiconductor company reported ($0.28) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.27) by ($0.01). The business had revenue of $57.30 million for the quarter, compared to analysts’ expectations of $57.12 million. Ambarella had a negative net margin of 9.97% and a negative return on equity of 5.35%. Ambarella’s revenue for the quarter was down 35.7% compared to the same quarter last year. During the same period last year, the company earned $0.75 earnings per share. As a group, equities research analysts anticipate that Ambarella Inc will post -1.02 EPS for the current year.

    WARNING: “JPMorgan Chase & Co. Buys 316,953 Shares of Ambarella Inc (AMBA)” was originally published by Ticker Report and is the property of of Ticker Report. If you are reading this report on another website, it was stolen and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be accessed at www.tickerreport.com/banking-finance/4153433/jpmorgan-chase-co-buys-316953-shares-of-ambarella-inc-amba.html.

    Ambarella Profile

  • [By Stephan Byrd]

    Ambarella (NASDAQ:AMBA) and Hanwha Q Cells (NASDAQ:HQCL) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and profitability.

Top 10 High Tech Stocks To Buy For 2019: Blackrock Global(BGT)

Advisors’ Opinion:

  • [By Max Byerly]

    Cornerstone Advisory LLP reduced its stake in shares of BlackRock Floating Rate Income Trust (NYSE:BGT) by 34.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 37,398 shares of the investment management company’s stock after selling 19,999 shares during the quarter. Cornerstone Advisory LLP’s holdings in BlackRock Floating Rate Income Trust were worth $489,000 at the end of the most recent quarter.

Top 10 High Tech Stocks To Buy For 2019: First Interstate BancSystem Inc.(FIBK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on First Interstate BancSystem (FIBK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Sun Life Financial INC purchased a new position in shares of First Interstate Bancsystem Inc (NASDAQ:FIBK) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,814 shares of the financial services provider’s stock, valued at approximately $414,000.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on First Interstate Bancsystem (FIBK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    First Interstate Bancsystem Inc (NASDAQ:FIBK) has been given an average recommendation of “Buy” by the eight ratings firms that are presently covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $46.33.

  • [By Max Byerly]

    Massachusetts Financial Services Co. MA lifted its stake in shares of First Interstate BancSystem (NASDAQ:FIBK) by 4.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 464,152 shares of the financial services provider’s stock after acquiring an additional 20,543 shares during the period. Massachusetts Financial Services Co. MA owned 0.82% of First Interstate BancSystem worth $18,357,000 as of its most recent SEC filing.

Top 10 High Tech Stocks To Buy For 2019: SodaStream International Ltd.(SODA)

Advisors’ Opinion:

  • [By Demitrios Kalogeropoulos]

    SodaStream (NASDAQ:SODA) recently announced surprisingly strong first-quarter earnings as sales growth sped up to a 25% pace and profitability improved. The seller of at-home carbonated beverage machines is benefiting from a long-term trend of rising global demand for sparkling water.

  • [By Rick Munarriz]

    Sometimes it takes years for buyout chatter to finally materialize. PepsiCo (NASDAQ:PEP) is announcing that it will be acquiring SodaStream (NASDAQ:SODA) in an all-cash deal valued at $3.2 billion. Both boards have approved the transaction that will cash out SodaStream investors at $144 a share. The purchase is expected to close in January, as long as the majority of SodaStream shareholders vote in favor of the deal.

  • [By Keith Noonan]

    SodaStream (NASDAQ:SODA) stock climbed 63.5 % in August, according to data provided by S&P Global Market Intelligence. The company’s share price skyrocketed following blockbuster quarterly results, then posted more big gains later in the month on news that the business was being acquired by PepsiCo (NASDAQ:PEP).

Top 10 High Tech Stocks To Buy For 2019: Adaptimmune Therapeutics plc(ADAP)

Advisors’ Opinion:

  • [By Logan Wallace]

    Adaptimmune Therapeutics (NASDAQ:ADAP) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.

  • [By Logan Wallace]

    Here are some of the news stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get Adaptimmune Therapeutics alerts:

    Analysts Anticipate Adaptimmune Therapeutics PLC – (ADAP) to Post -$0.28 Earnings Per Share (americanbankingnews.com) Peritoneal Cancer Market Pipeline Review H1- Target Drug Profile, Top Industry Intelligence, Major Key Players and … (thefreenewsman.com) Escherichia coli Infections Market Research Report Pipeline Review H1 Assessment by Mechanism of Action, Drug … (theperfectinvestor.com) Adaptimmune Therapeutics plc (ADAP): Do You Have This Stock in Portfolio?: (bitcoinpriceupdate.review)

    Several equities analysts have weighed in on the company. Leerink Swann reissued an “outperform” rating on shares of Adaptimmune Therapeutics in a report on Thursday, March 15th. BidaskClub downgraded Adaptimmune Therapeutics from a “hold” rating to a “sell” rating in a research report on Wednesday. ValuEngine upgraded Adaptimmune Therapeutics from a “buy” rating to a “strong-buy” rating in a research report on Monday. SunTrust Banks increased their target price on Adaptimmune Therapeutics to $18.00 and gave the stock a “buy” rating in a research report on Thursday, May 10th. Finally, Cowen restated a “buy” rating on shares of Adaptimmune Therapeutics in a research report on Wednesday, May 9th. Two equities research analysts have rated the stock with a sell rating, four have given a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $16.94.

  • [By Stephan Byrd]

    Adaptimmune Therapeutics (NASDAQ:ADAP) was downgraded by stock analysts at TheStreet from a “c-” rating to a “d+” rating in a research report issued to clients and investors on Monday.

  • [By ]

    Adaptimmune Therapeutics (ADAP) : “If you’ve speculated on this one, you’ve won. Let’s move on.”

    Icahn Enterprises (IEP) : “I don’t really know what they own so I can’t recommend it.”

  • [By Ethan Ryder]

    Adaptimmune Therapeutics (NASDAQ:ADAP) announced its quarterly earnings data on Wednesday. The biotechnology company reported ($0.04) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.24) by $0.20, Bloomberg Earnings reports. Adaptimmune Therapeutics had a negative return on equity of 32.26% and a negative net margin of 185.39%. During the same quarter in the prior year, the business earned ($3.00) EPS.

Top 10 High Tech Stocks To Buy For 2019: Liberty Tax, Inc.(TAX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Acacia Research (NASDAQ: ACTG) and Liberty Tax (NASDAQ:TAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.

Top 10 High Tech Stocks To Buy For 2019: Panasonic Corporation (PCRFY)

Advisors’ Opinion:

  • [By ]

    However, Panasonic (OTCPK:PCRFY) announced this week that it was happy to consider further investment in the Nevada facility. A similar move in China is not unlikely. Tesla expects to triple its energy storage business this year but its problem has been getting supply to meet the demand. Panasonic’s announcement is probably connected to a very substantial energy storage contract win just announced by the company.

  • [By ]

    The production issue for batteries may improve with added input from partner Panasonic (OTCPK:PCRFY). They currently produce battery cells for Tesla in Nevada, and in Japan. At their recent earnings call CEO Kazuhiro Tsuga said they were looking at manufacturing battery cells at a new plant in China in conjunction with Tesla. They also predicted their automation energy business profit would double this year. This can be seen as a vote of confidence in Tesla and a bullish sign for Tesla stock. However, according to reports in the Nikkei Asian Review, there is as yet no definite commitment for a joint venture in China. Panasonic is the world’s largest battery supplier for EV’s.

  • [By SEEKINGALPHA.COM]

    JOLED is a company that was established in 2014 by by Japan Display, Sony (NYSE:SNE) and Panasonic (OTCPK:PCRFY). And they are not the only ones:

    During an OLED display Seminar in Korea, UniJet’s CEO Kim Seok-Soon said that new advances in Ink-Jet printing technologies could enable displays that are over 500 PPI – and so make printing a viable technology to produce small and medium-sized OLED panels.

Top 10 High Tech Stocks To Buy For 2019: Orange(ORAN)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Orange (ORAN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Anders Bylund, Timothy Green, and Dan Caplinger]

    The trick is to separate high-quality income generators from their lower-quality peers. So we asked a few of your fellow investors here at The Motley Fool to share their best dividend ideas with yields of 4% or more. Read on to see why they recommend tech titan International Business Machines (NYSE:IBM), international telecom Orange (NYSE:ORAN), and energy giant ExxonMobil (NYSE:XOM).

  • [By Shane Hupp]

    ValuEngine downgraded shares of Orange (NYSE:ORAN) from a buy rating to a hold rating in a research report released on Monday morning.

    ORAN has been the topic of several other reports. Zacks Investment Research cut Orange from a hold rating to a sell rating in a research report on Wednesday, April 25th. BNP Paribas raised Orange from an underperform rating to a neutral rating in a research report on Tuesday, January 23rd. Two analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. Orange has a consensus rating of Hold and an average price target of $19.00.

Best Clean Energy Stocks To Own For 2019

If you’re looking to invest in renewable power stocks, you can always pick out pure plays that take advantage of the huge demand for clean energy —  and with utility customers inking long-term power contracts as they switch from dirty carbon-based fuels, that might be a winning strategy. However, what if the growth story behind renewables doesn’t live up to today’s hype?

That uncertainty is why a diversified company like NextEra Energy, Inc. (NYSE:NEE), with utility and renewable power operations, might make more sense for conservative investors.

Focusing on renewables

There’s no question that a company like Brookfield Renewable Partners L.P. (NYSE:BEP) is a great direct play on renewable power. Roughly 80% of the company’s power is hydroelectric, with the rest made up largely of wind and solar. Moreover, it has exposure to Brazil (20% of generation) and Columbia (15%), in addition to the United States (60%). Much of the company’s growth has come from acquisitions, and long-term contracts back up the bulk of its revenues. It’s a perfectly fine renewable power investment.

Best Clean Energy Stocks To Own For 2019: John B. Sanfilippo & Son, Inc.(JBSS)

Advisors’ Opinion:

  • [By Max Byerly]

    John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) shares reached a new 52-week high and low during trading on Wednesday . The stock traded as low as $71.43 and last traded at $70.96, with a volume of 1305 shares trading hands. The stock had previously closed at $69.72.

  • [By Max Byerly]

    The Hershey (NYSE: HSY) and John B. Sanfilippo & Son (NASDAQ:JBSS) are both consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

  • [By Stephan Byrd]

    WINTON GROUP Ltd acquired a new position in shares of John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) in the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 21,466 shares of the company’s stock, valued at approximately $1,242,000. WINTON GROUP Ltd owned about 0.19% of John B. Sanfilippo & Son at the end of the most recent quarter.

  • [By Ethan Ryder]

    John B. Sanfilippo & Son, Inc. (NASDAQ:JBSS) CEO Jeffrey T. Sanfilippo sold 8,108 shares of the firm’s stock in a transaction that occurred on Thursday, August 30th. The shares were sold at an average price of $71.00, for a total transaction of $575,668.00. Following the completion of the sale, the chief executive officer now directly owns 14,840 shares in the company, valued at approximately $1,053,640. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Best Clean Energy Stocks To Own For 2019: TrueBlue Inc.(TBI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Trueblue (NYSE: TBI) is one of 23 public companies in the “Help supply services” industry, but how does it contrast to its rivals? We will compare Trueblue to similar businesses based on the strength of its analyst recommendations, institutional ownership, valuation, profitability, dividends, earnings and risk.

  • [By Stephan Byrd]

    American Century Companies Inc. grew its holdings in shares of Trueblue Inc (NYSE:TBI) by 24.4% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 95,307 shares of the business services provider’s stock after purchasing an additional 18,680 shares during the period. American Century Companies Inc. owned approximately 0.23% of Trueblue worth $2,468,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Russell Investments Group Ltd. grew its stake in Trueblue Inc (NYSE:TBI) by 21.2% during the first quarter, HoldingsChannel reports. The fund owned 137,178 shares of the business services provider’s stock after purchasing an additional 23,951 shares during the quarter. Russell Investments Group Ltd.’s holdings in Trueblue were worth $3,553,000 at the end of the most recent quarter.

  • [By Motley Fool Transcribers]

    TrueBlue Inc  (NYSE:TBI)Q4 2018 Earnings Conference CallFeb. 07, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.

  • [By Logan Wallace]

    Media stories about Trueblue (NYSE:TBI) have trended somewhat positive on Monday, according to Accern Sentiment. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Trueblue earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media stories about the business services provider an impact score of 45.3296498009881 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Best Clean Energy Stocks To Own For 2019: Adaptimmune Therapeutics plc(ADAP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Adaptimmune Therapeutics (NASDAQ:ADAP) announced its quarterly earnings data on Wednesday. The biotechnology company reported ($0.04) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.24) by $0.20, Bloomberg Earnings reports. Adaptimmune Therapeutics had a negative return on equity of 32.26% and a negative net margin of 185.39%. During the same quarter in the prior year, the business earned ($3.00) EPS.

  • [By Stephan Byrd]

    Adaptimmune Therapeutics (NASDAQ:ADAP) was downgraded by stock analysts at TheStreet from a “c-” rating to a “d+” rating in a research report issued to clients and investors on Monday.

  • [By Logan Wallace]

    Adaptimmune Therapeutics (NASDAQ:ADAP) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.

  • [By ]

    Adaptimmune Therapeutics (ADAP) : “If you’ve speculated on this one, you’ve won. Let’s move on.”

    Icahn Enterprises (IEP) : “I don’t really know what they own so I can’t recommend it.”

  • [By Logan Wallace]

    Here are some of the news stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get Adaptimmune Therapeutics alerts:

    Analysts Anticipate Adaptimmune Therapeutics PLC – (ADAP) to Post -$0.28 Earnings Per Share (americanbankingnews.com) Peritoneal Cancer Market Pipeline Review H1- Target Drug Profile, Top Industry Intelligence, Major Key Players and … (thefreenewsman.com) Escherichia coli Infections Market Research Report Pipeline Review H1 Assessment by Mechanism of Action, Drug … (theperfectinvestor.com) Adaptimmune Therapeutics plc (ADAP): Do You Have This Stock in Portfolio?: (bitcoinpriceupdate.review)

    Several equities analysts have weighed in on the company. Leerink Swann reissued an “outperform” rating on shares of Adaptimmune Therapeutics in a report on Thursday, March 15th. BidaskClub downgraded Adaptimmune Therapeutics from a “hold” rating to a “sell” rating in a research report on Wednesday. ValuEngine upgraded Adaptimmune Therapeutics from a “buy” rating to a “strong-buy” rating in a research report on Monday. SunTrust Banks increased their target price on Adaptimmune Therapeutics to $18.00 and gave the stock a “buy” rating in a research report on Thursday, May 10th. Finally, Cowen restated a “buy” rating on shares of Adaptimmune Therapeutics in a research report on Wednesday, May 9th. Two equities research analysts have rated the stock with a sell rating, four have given a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $16.94.

  • [By ]

    Cramer was bearish on Chesapeake Energy (CHK) , Adaptimmune Therapeutics (ADAP) , Icahn Enterprises (IEP) , Bristol-Myers Squibb (BMY) , Quad/Graphics (QUAD) , Spectra Energy Partners (SEP) and L Brands (LB) .

Best Clean Energy Stocks To Own For 2019: SPDR S&P Bank ETF (KBE)

Advisors’ Opinion:

  • [By Jim Crumly]

    Several big banks reported earnings, but their shares slumped today; the SPDR S&P Bank ETF (NYSEMKT:KBE) fell 1.1%. Consumer stocks had a good showing, with the Consumer Staples Select Sector SPDR ETF (NYSEMKT:XLP) up 0.7%.

  • [By Max Byerly]

    Key Square Capital Management LLC bought a new position in shares of SPDR KBW Bank (NYSEARCA:KBE) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 403,000 shares of the exchange traded fund’s stock, valued at approximately $19,300,000. SPDR KBW Bank comprises 2.2% of Key Square Capital Management LLC’s portfolio, making the stock its 13th biggest position.

  • [By Logan Wallace]

    SPDR KBW Bank (NYSEARCA:KBE) announced a quarterly dividend on Monday, June 18th, Wall Street Journal reports. Investors of record on Monday, June 18th will be paid a dividend of 0.1697 per share by the exchange traded fund on Wednesday, June 20th. This represents a $0.68 annualized dividend and a dividend yield of 1.38%. The ex-dividend date is Friday, June 15th. This is a boost from SPDR KBW Bank’s previous quarterly dividend of $0.16.

  • [By Jim Crumly]

    Retail had a good session, with the SPDR S&P Retail ETF (NYSEMKT:XRT) jumping 2.3%. Bank stocks also rose as long-term interest rates moved up; the SPDR S&P Bank ETF (NYSEMKT:KBE) added 1.3%. 

  • [By WWW.GURUFOCUS.COM]

    For the details of KELLOGG W K FOUNDATION TRUST’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=KELLOGG+W+K+FOUNDATION+TRUST

    These are the top 5 holdings of KELLOGG W K FOUNDATION TRUSTKellogg Co (K) – 67,606,838 shares, 98.23% of the total portfolio. Shares reduced by 0.48%SPDR Select Sector Fund – Energy Select Sector (XLE) – 769,255 shares, 1.19% of the total portfolio. SPDR S&P Bank (KBE) – 534,408 shares, 0.54% of the total portfolio. Shares reduced by 37.08%MuleSoft Inc (MULE) – 73,513 shares, 0.04% of the total portfolio. New PositioniShares Russell 1000 Value (IWD) – 0 shares, 0% of the total portfol

Top 10 Clean Energy Stocks To Watch For 2019

There’s reason to think that President Trump might target uranium imports for tariffs after imposing them on solar equipment back in January and then another announcing another round late last week on steel and aluminum (China has already responded by announcing planned tariffs on imports of U.S. pork, recycled aluminum, steel pipes, fruit and wine). At first glance, you might think that would cause concern for investors in small cap mining stocks like Azincourt Energy Corp (TSX-V: AAZ; OTCMKTS: AZURF) which is focused on developing critical clean energy elements (namely lithium, uranium and cobalt plus other critical clean energy elements) mostly in Canada.

However, Trump did quickly declared a temporary exemption from his tariffs for the European Union and other nations like Australia and South Korea as the tariffs are clearly meant to hit China. The NAFTA countries of Canada and Mexico were also exempted; but those exemptions “are not open-ended” and will depend on whether changes are made to NAFTA that will satisfy Trump.

Top 10 Clean Energy Stocks To Watch For 2019: Chunghwa Telecom Co., Ltd.(CHT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Chunghwa Telecom (NYSE: CHT) and NII (NASDAQ:NIHD) are both utilities companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk.

  • [By Joseph Griffin]

    News stories about Chunghwa Telecom (NYSE:CHT) have trended positive on Monday, according to Accern Sentiment. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Chunghwa Telecom earned a media sentiment score of 0.25 on Accern’s scale. Accern also assigned press coverage about the utilities provider an impact score of 46.731481807669 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Logan Wallace]

    Evergreen Capital Management LLC purchased a new stake in shares of Chunghwa Telecom Co., Ltd (NYSE:CHT) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 5,755 shares of the utilities provider’s stock, valued at approximately $224,000.

Top 10 Clean Energy Stocks To Watch For 2019: Portola Pharmaceuticals, Inc.(PTLA)

Advisors’ Opinion:

  • [By Brian Orelli]

    Shares of Portola Pharmaceuticals (NASDAQ:PTLA) fell 16.6% in August, according to data provided by S&P Global Market Intelligence. The drop came after the biotech posted second-quarter results that disappointed investors. Though the company has launched two drugs this year, sales of Bevyxxa, an anticoagulant that launched in January, came in at just $33,000, and sales of its factor Xa anticoagulant reversal agent, Andexxa, tallied $2.2 million.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Portola Pharmaceuticals (PTLA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Portola Pharmaceuticals (PTLA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Demitrios Kalogeropoulos]

    Portola Pharmaceuticals (NASDAQ:PTLA) lagged the market last month by falling 11% compared to a 0.4% increase in the S&P 500, according to data provided by S&P Global Market Intelligence.

Top 10 Clean Energy Stocks To Watch For 2019: Preferred Bank(PFBC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Preferred Bank (PFBC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Sei Investments Co. decreased its position in shares of Preferred Bank (NASDAQ:PFBC) by 10.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,114 shares of the bank’s stock after selling 1,803 shares during the quarter. Sei Investments Co.’s holdings in Preferred Bank were worth $970,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Headlines about Preferred Bank (NASDAQ:PFBC) have trended somewhat positive on Wednesday, Accern Sentiment reports. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Preferred Bank earned a daily sentiment score of 0.15 on Accern’s scale. Accern also gave media coverage about the bank an impact score of 47.398079324348 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Preferred Bank (PFBC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Summit Global Investments lifted its position in Preferred Bank (NASDAQ:PFBC) by 8.6% in the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 10,100 shares of the bank’s stock after purchasing an additional 800 shares during the period. Summit Global Investments owned 0.08% of Preferred Bank worth $621,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Preferred Bank (PFBC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Clean Energy Stocks To Watch For 2019: Coherent, Inc.(COHR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Hood River Capital Management LLC decreased its position in shares of Coherent, Inc. (NASDAQ:COHR) by 63.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 69,773 shares of the scientific and technical instruments company’s stock after selling 122,518 shares during the quarter. Hood River Capital Management LLC owned about 0.28% of Coherent worth $13,075,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Benchmark restated their buy rating on shares of Coherent (NASDAQ:COHR) in a research note published on Thursday morning. The firm currently has a $216.00 price objective on the scientific and technical instruments company’s stock.

  • [By Logan Wallace]

    Coherent (NASDAQ: COHR) and Integra Lifesciences (NASDAQ:IART) are both mid-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, profitability, institutional ownership, dividends and valuation.

Top 10 Clean Energy Stocks To Watch For 2019: Olympic Steel Inc.(ZEUS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Olympic Steel, Inc. (NASDAQ:ZEUS) – Jefferies Financial Group boosted their Q2 2018 earnings per share (EPS) estimates for Olympic Steel in a report released on Tuesday, July 10th. Jefferies Financial Group analyst S. Rosenfeld now anticipates that the basic materials company will earn $1.01 per share for the quarter, up from their previous forecast of $0.90. Jefferies Financial Group also issued estimates for Olympic Steel’s Q3 2018 earnings at $0.50 EPS, Q4 2018 earnings at $0.09 EPS, FY2018 earnings at $2.29 EPS and FY2019 earnings at $2.37 EPS.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Olympic Steel (ZEUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Headlines about Olympic Steel (NASDAQ:ZEUS) have been trending somewhat positive on Tuesday, Accern reports. Accern identifies negative and positive press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Olympic Steel earned a news sentiment score of 0.13 on Accern’s scale. Accern also gave news coverage about the basic materials company an impact score of 47.5465348320487 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Joseph Griffin]

    Olympic Steel (NASDAQ:ZEUS) was downgraded by investment analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a research report issued to clients and investors on Friday.

Top 10 Clean Energy Stocks To Watch For 2019: First BanCorp.(FBP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    First Bancorp (NYSE:FBP) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a report issued on Friday.

  • [By Stephan Byrd]

    Shares of First Bancorp (NYSE:FBP) have earned an average rating of “Buy” from the eight brokerages that are presently covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy rating. The average twelve-month price objective among brokerages that have covered the stock in the last year is $9.63.

  • [By Ethan Ryder]

    Voya Investment Management LLC lowered its position in First Bancorp (NYSE:FBP) by 83.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 400,520 shares of the bank’s stock after selling 1,959,886 shares during the period. Voya Investment Management LLC owned approximately 0.19% of First Bancorp worth $3,064,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Prudential Financial Inc. lessened its position in First BanCorp (NYSE:FBP) by 16.5% in the first quarter, Holdings Channel reports. The institutional investor owned 906,869 shares of the bank’s stock after selling 179,820 shares during the period. Prudential Financial Inc.’s holdings in First BanCorp were worth $5,459,000 at the end of the most recent quarter.

Top 10 Clean Energy Stocks To Watch For 2019: Tekla Healthcare Investors(HQH)

Advisors’ Opinion:

  • [By Logan Wallace]

    Bank of Nova Scotia cut its stake in shares of Tekla Healthcare Investors (NYSE:HQH) by 19.7% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 69,440 shares of the financial services provider’s stock after selling 17,077 shares during the period. Bank of Nova Scotia owned about 0.17% of Tekla Healthcare Investors worth $1,493,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Tekla Healthcare Investors (NYSE:HQH) announced a quarterly dividend on Monday, August 20th, Wall Street Journal reports. Shareholders of record on Tuesday, August 28th will be given a dividend of 0.47 per share by the financial services provider on Friday, September 28th. This represents a $1.88 dividend on an annualized basis and a yield of 8.29%. The ex-dividend date of this dividend is Monday, August 27th.

Top 10 Clean Energy Stocks To Watch For 2019: Abbott Laboratories(ABT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Charter Trust Co. lowered its position in Abbott Laboratories (NYSE:ABT) by 1.4% in the 2nd quarter, HoldingsChannel reports. The fund owned 164,048 shares of the healthcare product maker’s stock after selling 2,350 shares during the quarter. Abbott Laboratories accounts for 1.2% of Charter Trust Co.’s holdings, making the stock its 23rd biggest holding. Charter Trust Co.’s holdings in Abbott Laboratories were worth $10,005,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Abbott Laboratories (ABT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Cramer and the AAP team note that seven of the companies in their portfolio are reporting this week, including Abbott Laboratories (ABT) , Nucor (NUE) and Honeywell (HON) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By Ethan Ryder]

    Martin & Co. Inc. TN boosted its holdings in Abbott Laboratories (NYSE:ABT) by 3.1% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 31,792 shares of the healthcare product maker’s stock after purchasing an additional 945 shares during the quarter. Martin & Co. Inc. TN’s holdings in Abbott Laboratories were worth $1,939,000 as of its most recent SEC filing.

Top 10 Clean Energy Stocks To Watch For 2019: Adaptimmune Therapeutics plc(ADAP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Adaptimmune Therapeutics (NASDAQ:ADAP) announced its quarterly earnings data on Wednesday. The biotechnology company reported ($0.04) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.24) by $0.20, Bloomberg Earnings reports. Adaptimmune Therapeutics had a negative return on equity of 32.26% and a negative net margin of 185.39%. During the same quarter in the prior year, the business earned ($3.00) EPS.

  • [By Logan Wallace]

    Here are some of the news stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get Adaptimmune Therapeutics alerts:

    Analysts Anticipate Adaptimmune Therapeutics PLC – (ADAP) to Post -$0.28 Earnings Per Share (americanbankingnews.com) Peritoneal Cancer Market Pipeline Review H1- Target Drug Profile, Top Industry Intelligence, Major Key Players and … (thefreenewsman.com) Escherichia coli Infections Market Research Report Pipeline Review H1 Assessment by Mechanism of Action, Drug … (theperfectinvestor.com) Adaptimmune Therapeutics plc (ADAP): Do You Have This Stock in Portfolio?: (bitcoinpriceupdate.review)

    Several equities analysts have weighed in on the company. Leerink Swann reissued an “outperform” rating on shares of Adaptimmune Therapeutics in a report on Thursday, March 15th. BidaskClub downgraded Adaptimmune Therapeutics from a “hold” rating to a “sell” rating in a research report on Wednesday. ValuEngine upgraded Adaptimmune Therapeutics from a “buy” rating to a “strong-buy” rating in a research report on Monday. SunTrust Banks increased their target price on Adaptimmune Therapeutics to $18.00 and gave the stock a “buy” rating in a research report on Thursday, May 10th. Finally, Cowen restated a “buy” rating on shares of Adaptimmune Therapeutics in a research report on Wednesday, May 9th. Two equities research analysts have rated the stock with a sell rating, four have given a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $16.94.

  • [By ]

    Cramer was bearish on Chesapeake Energy (CHK) , Adaptimmune Therapeutics (ADAP) , Icahn Enterprises (IEP) , Bristol-Myers Squibb (BMY) , Quad/Graphics (QUAD) , Spectra Energy Partners (SEP) and L Brands (LB) .

  • [By Logan Wallace]

    Adaptimmune Therapeutics (NASDAQ:ADAP) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.

  • [By Stephan Byrd]

    Adaptimmune Therapeutics (NASDAQ:ADAP) was downgraded by stock analysts at TheStreet from a “c-” rating to a “d+” rating in a research report issued to clients and investors on Monday.

Top 10 Clean Energy Stocks To Watch For 2019: Union Bankshares Corporation(UBSH)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Union Bankshares (UBSH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Union Bankshares (NASDAQ:UBSH) was upgraded by investment analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a report released on Thursday.

  • [By Motley Fool Staff]

    Union First Market Bankshares (NASDAQ:UBSH) Q2 2018 Earnings Conference CallJul. 18, 2018 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator 

Best Tech Stocks To Invest In 2019

Rajesh Palviya

Bharat Petroleum Corporation has given a downward sloping trendline breakout at Rs 400 which was also the immediate acting resistance in the stock and went on to make a high of Rs 411.50 on a closing basis.

The stock is witnessing high volume along with the support placed at 20 and 50-days SMA. The momentum indicators are also signaling a positive probability towards the bullish momentum in the stock.

We are recommending buying the stock in the rangeof Rs 408-400with targetat Rs 430-437and stop lossof Rs 391with return of 7 percent.

Disclaimer: The author is Head-Technical & Derivative Research, Axis Securities. The views and investment tips expressed by investment experts on moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Best Tech Stocks To Invest In 2019: Brooks Automation Inc.(BRKS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Brooks Automation (NASDAQ:BRKS) insider Maurice H. Tenney sold 8,969 shares of Brooks Automation stock in a transaction on Wednesday, May 16th. The stock was sold at an average price of $29.80, for a total transaction of $267,276.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Shane Hupp]

    Shares of Brooks Automation, Inc (NASDAQ:BRKS) have been assigned an average recommendation of “Buy” from the ten analysts that are presently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $34.00.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Brooks Automation (BRKS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    BNP Paribas Arbitrage SA reduced its stake in Brooks Automation, Inc (NASDAQ:BRKS) by 21.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 22,761 shares of the semiconductor company’s stock after selling 6,086 shares during the quarter. BNP Paribas Arbitrage SA’s holdings in Brooks Automation were worth $616,000 at the end of the most recent reporting period.

Best Tech Stocks To Invest In 2019: Adaptimmune Therapeutics plc(ADAP)

Advisors’ Opinion:

  • [By Logan Wallace]

    Here are some of the news stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get Adaptimmune Therapeutics alerts:

    Analysts Anticipate Adaptimmune Therapeutics PLC – (ADAP) to Post -$0.28 Earnings Per Share (americanbankingnews.com) Peritoneal Cancer Market Pipeline Review H1- Target Drug Profile, Top Industry Intelligence, Major Key Players and … (thefreenewsman.com) Escherichia coli Infections Market Research Report Pipeline Review H1 Assessment by Mechanism of Action, Drug … (theperfectinvestor.com) Adaptimmune Therapeutics plc (ADAP): Do You Have This Stock in Portfolio?: (bitcoinpriceupdate.review)

    Several equities analysts have weighed in on the company. Leerink Swann reissued an “outperform” rating on shares of Adaptimmune Therapeutics in a report on Thursday, March 15th. BidaskClub downgraded Adaptimmune Therapeutics from a “hold” rating to a “sell” rating in a research report on Wednesday. ValuEngine upgraded Adaptimmune Therapeutics from a “buy” rating to a “strong-buy” rating in a research report on Monday. SunTrust Banks increased their target price on Adaptimmune Therapeutics to $18.00 and gave the stock a “buy” rating in a research report on Thursday, May 10th. Finally, Cowen restated a “buy” rating on shares of Adaptimmune Therapeutics in a research report on Wednesday, May 9th. Two equities research analysts have rated the stock with a sell rating, four have given a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $16.94.

  • [By ]

    Adaptimmune Therapeutics (ADAP) : “If you’ve speculated on this one, you’ve won. Let’s move on.”

    Icahn Enterprises (IEP) : “I don’t really know what they own so I can’t recommend it.”

  • [By Ethan Ryder]

    Adaptimmune Therapeutics (NASDAQ:ADAP) announced its quarterly earnings data on Wednesday. The biotechnology company reported ($0.04) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.24) by $0.20, Bloomberg Earnings reports. Adaptimmune Therapeutics had a negative return on equity of 32.26% and a negative net margin of 185.39%. During the same quarter in the prior year, the business earned ($3.00) EPS.

  • [By ]

    Cramer was bearish on Chesapeake Energy (CHK) , Adaptimmune Therapeutics (ADAP) , Icahn Enterprises (IEP) , Bristol-Myers Squibb (BMY) , Quad/Graphics (QUAD) , Spectra Energy Partners (SEP) and L Brands (LB) .

Best Tech Stocks To Invest In 2019: Schwab US Large-Cap ETF (SCHX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Milestone Group Inc. decreased its stake in Schwab US Large-Cap ETF (NYSEARCA:SCHX) by 4.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 63,425 shares of the company’s stock after selling 2,710 shares during the period. Schwab US Large-Cap ETF makes up 0.7% of Milestone Group Inc.’s investment portfolio, making the stock its 19th largest holding. Milestone Group Inc.’s holdings in Schwab US Large-Cap ETF were worth $4,001,000 as of its most recent filing with the Securities & Exchange Commission.